Conference 1: Cardiovascular Risk Assessment
Informa Life Sciences’ Cardiovascular Risk Assessment has been specifically designed to reflect the latest scientific and technological breakthroughs for assessing cardiac risk in both the preclinical and clinical environment. From overcoming the difficulties of QT assessment for drugs which affect the heart rate, novel methodologies for oncology & diabetes safety assessment to biomarkers to predict cardiotoxicity. Dealing with ion channel liabilities to limits allowed for blood pressure changes. This industry led interactive forum will enable you to stay one step ahead of the competition offering you the chance to discover strategic approaches to improve trial designs.
Conference 2: Drug Induced Liver Injury
Informa Life Sciences’ Drug Induced Liver Injury is the only DILI focused event in Europe bridging the gap between pre-clinical and clinical research. Now in its second year the programme has been developed though rigorous research with key academic and industry experts in hepatotoxicity; this programme has been specifically designed to provide you with a tailored package of knowledge to propel your DILI testing strategy to the next level.